Ilona E Kryczek
Associate Research Scientist
Surgery
Medical School
[email protected]

Available to mentor
Ilona E Kryczek
Associate Research Scientist
  • Recent Publications
    • Manage Your Profile
    Recent Publications See All Publications
    • Journal Article
      Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043
      Zakharia Y, Singer EA, Acharyya S, Garje R, Joshi M, Peace D, Baladandayuthapani V, Majumdar A, Li X, Lalancette C, Kryczek I, Zou W, Alva A. Nature Communications, 2024 Dec 1; 15 (1): DOI:10.1038/s41467-024-45216-z
      PMID: 38302476
    • Journal Article
      PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages
      Pitter MR, Kryczek I, Zhang H, Nagarsheth N, Xia H, Wu Z, Tian Y, Okla K, Liao P, Wang W, Zhou J, Li G, Lin H, Vatan L, Grove S, Wei S, Li Y, Zou W. Cell Reports, 2024 Mar 26; 43 (3): DOI:10.1016/j.celrep.2024.113942
      PMID: 38489266
    • Journal Article
      Microbiota-dependent activation of CD4<sup>+</sup> T cells induces CTLA-4 blockade–associated colitis via Fcg receptors
      Lo BC, Kryczek I, Yu J, Vatan L, Caruso R, Matsumoto M, Sato Y, Shaw MH, Inohara N, Xie Y, Lei YL, Zou W, Núñez G. Science, 2024 Jan 1; 383 (6678): 62 - 70. DOI:10.1126/science.adh8342
      PMID: 38175892
    • Journal Article
      PIKfyve controls dendritic cell function and tumor immunity
      Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Tien J, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, Vatan L, Lin H, Li G, Zheng Y, Zhang Y, Cao X, Su F, Rui W, He T, Gondal M, Cieslik M, Green M, Zou W, Chinnaiyan A. Nature Immunology, 2023 Jun 29;
    • Journal Article
      Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy
      Li G, Choi JE, Kryczek I, Sun Y, Liao P, Li S, Wei S, Grove S, Vatan L, Nelson R, Schaefer G, Allen SG, Sankar K, Fecher LA, Mendiratta-Lala M, Frankel TL, Qin A, Waninger JJ, Tezel A, Alva A, Lao CD, Ramnath N, Cieslik M, Harms PW, Green MD, Chinnaiyan AM, Zou W. Cancer Cell, 2023 Feb 13; 41 (2): 304 - 322.e7. DOI:10.1016/j.ccell.2022.12.008
      PMID: 36638784
    • Additional Scholarship
      Data from The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
      Bao Y, Cruz G, Zhang Y, Qiao Y, Mannan R, Hu J, Yang F, Gondal M, Shahine M, Kang S, Mahapatra S, Chu A, Choi JE, Yu J, Lin H, Miner SJ, Robinson DR, Wu Y-M, Zheng Y, Cao X, Su F, Wang R, Hosseini N, Cieslik M, Kryczek I, Vaishampayan U, Zou W, Chinnaiyan AM. 2025 Feb 7; DOI:10.1158/2159-8290.c.7662947
    • Additional Scholarship
      Figure 1 from The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
      Bao Y, Cruz G, Zhang Y, Qiao Y, Mannan R, Hu J, Yang F, Gondal M, Shahine M, Kang S, Mahapatra S, Chu A, Choi JE, Yu J, Lin H, Miner SJ, Robinson DR, Wu Y-M, Zheng Y, Cao X, Su F, Wang R, Hosseini N, Cieslik M, Kryczek I, Vaishampayan U, Zou W, Chinnaiyan AM. 2025 Feb 7; DOI:10.1158/2159-8290.28367837
    • Additional Scholarship
      Figure 2 from The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
      Bao Y, Cruz G, Zhang Y, Qiao Y, Mannan R, Hu J, Yang F, Gondal M, Shahine M, Kang S, Mahapatra S, Chu A, Choi JE, Yu J, Lin H, Miner SJ, Robinson DR, Wu Y-M, Zheng Y, Cao X, Su F, Wang R, Hosseini N, Cieslik M, Kryczek I, Vaishampayan U, Zou W, Chinnaiyan AM. 2025 Feb 7; DOI:10.1158/2159-8290.28367834